Literature DB >> 3614388

Effects of calcium channel blockers on the contractile response to dihydroergotamine in isolated human femoral veins.

E Glusa, F Markwardt.   

Abstract

Contractions induced in spirally cut human postmortem femoral veins by dihydroergotamine, noradrenaline, or 5-hydroxytryptamine (5-HT) were measured isometrically. The influence of calcium channel blockers (verapamil, diltiazem and nifedipine), lanthanum chloride and withdrawal of external calcium on the contractile response of veins to dihydroergotamine was investigated. The agonists noradrenaline and 5-HT were studied in comparison. Verapamil and nifedipine up to a concentration of 1 mumol/l caused a shift to the right of the cumulative concentration-response curves for noradrenaline and 5-HT with a reduction of the maximum contraction. Diltiazem affected the contractile response to 5-HT slightly. The venocontractions induced by dihydroergotamine at a concentration of 0.03 mumol/l were inhibited by the calcium channel blockers in a concentration-dependent manner. Verapamil was most effective, followed by nifedipine and diltiazem. In dihydroergotamine-precontracted veins nifedipine produced a more pronounced relaxation than verapamil. Lanthanum chloride (5 mmol/l) inhibited the dihydroergotamine-induced contraction by about 90%. Exposure of veins to a calcium-free medium for 30 min resulted in an inhibition of the dihydroergotamine-induced venocontraction by more than 90%. The addition of calcium ions to the medium caused an increase in the contraction with a maximum which closely resembled that of the control. The present studies demonstrate that the contractile response of human femoral veins to dihydroergotamine depends to a great extent on extracellular calcium. However, the calcium channel blockers verapamil, diltiazem and nifedipine, inhibit the agonist-induced venocontractions in part only.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3614388     DOI: 10.1007/bf00169119

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

Review 1.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Severe unilateral ischemia of the lower extremity caused by ergotamine: treatment with nifedipine.

Authors:  F J Dagher; S O Pais; W Richards; L A Queral
Journal:  Surgery       Date:  1985-03       Impact factor: 3.982

3.  The mechanism of inhibitory action of diltiazem on vascular smooth muscle contractility.

Authors:  C van Breemen; O Hwang; K D Meisheri
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

4.  Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.

Authors:  H J Motulsky; M D Snavely; R J Hughes; P A Insel
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

5.  Dual effect of dihydroergotamine and dihydroergotoxin in isolated human femoral veins and arteries.

Authors:  E Glusa; F Markwardt
Journal:  Pharmacology       Date:  1982       Impact factor: 2.547

6.  Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.

Authors:  E Glusa; F Markwardt
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

7.  Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.

Authors:  I Cavero; N Shepperson; F Lefèvre-Borg; S Z Langer
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

8.  Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets.

Authors:  H Affolter; W P Burkard; A Pletscher
Journal:  Eur J Pharmacol       Date:  1985-01-22       Impact factor: 4.432

9.  Verapamil as an apparent competitive antagonist of the serotonin receptor of rabbit isolated aorta.

Authors:  M Auguet; S Delaflotte; F Clostre; F V DeFeudis
Journal:  Gen Pharmacol       Date:  1986

10.  Effects of inhibitors of arachidonic acid metabolism and calcium entry on responses to acetylcholine, potassium and norepinephrine in the isolated canine saphenous vein.

Authors:  T J Rimele; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1983-06       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.